SRD5A2 gene polymorphisms affect the risk of breast cancer

Amirtharaj Francis, Saumya Sarkar, Singh Pooja, Daminani Surekha, Digumarthi Raghunatha Rao, Lakshmi Rao, Lingadakai Ramachandra, Satti Vishnupriya, Kapaettu Satyamoorthy, Kumarasamy Thangaraj, Singh Rajender

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)


Androgens in breast cancer have been studied alone and in correlation with estrogens as estrogen to testosterone ratio. 5-α-reductase is one of the important enzymes participating in androgen metabolism, which affects androgen activity by affecting conversion of testosterone to dihydrotestosterone. We hypothesized that polymorphisms in the SRD5A2 gene (encoding 5-α-reductase) may affect breast cancer risk by affecting total androgen activity. Complete coding region of the SRD5A2 gene was sequenced in a group of 628 patients and 244 control samples from three southern states (Tamil Nadu, Andhra Pradesh, and Karnataka) of India. We observed three common polymorphisms in this gene namely, A49T, V89L, and (TA)n repeats. A49T locus was monomorphic in the study population, but V89L showed a strong correlation with breast cancer (P=0.03, OR=1.40, CI=1.02-1.91). (TA)0/(TA)9 and (TA)9/(TA)9 genotypes were at a lower risk of breast cancer (P=0.01, OR=0.64, CI=0.46-0.90). We conclude that SRD5A2 genotypes significantly affect breast cancer risk in the South Indian populations.

Original languageEnglish
Pages (from-to)137-141
Number of pages5
Issue number2
Publication statusPublished - 2014

All Science Journal Classification (ASJC) codes

  • Surgery
  • Medicine(all)


Dive into the research topics of 'SRD5A2 gene polymorphisms affect the risk of breast cancer'. Together they form a unique fingerprint.

Cite this